Evidence map›Paper›PMID 26186506›Full record

Observational studyJournal of acquired immune deficiency syndromes (1999)2015

Raised Venous Lactate and Markers of Intestinal Translocation Are Associated With Mortality Among In-Patients With HIV-Associated TB in Rural South Africa.

Sathyavani Subbarao, Katalin A Wilkinson, Clare L van Halsema, Suhasini Subba Rao, Tom Boyles, Netanya S Utay, Robert J Wilkinson, Graeme Meintjes

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Journal of acquired immune deficiency syndromes (1999), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Tuberculosis deaths are predictable and preventable: Comprehensive assessment and clinical care is the key.Journal of clinical tuberculosis and other mycobacterial diseases · 2020
    Article
  7. Article
  8. Observational
  9. Review
  10. Article
  11. Article
  12. Article
  13. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Sathyavani Subbarao*Madwaleni Hospital, Elliotdale, South Africa; †Clinical Infectious Diseases Research Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; ‡Department of Medicine, University of Cape Town, Cape Town, South Africa; §MRC National Institute for Medical Research, London, United Kingdom; ‖Monsall Unit, Department of Infectious Diseases and Tropical Medicine, North Manchester General Hospital, Manchester, United Kingdom; ¶Department of Statistics, Texas A&M University, College Station, TX; #National Science Foundation, Arlington, VA; **Infectious Diseases Division, Department of Internal Medicine, University of Texas Medical Branch at Galveston, Galveston, TX; and ††Department of Medicine, Imperial College, London, United Kingdom.
Katalin A Wilkinson
Clare L van Halsema
Suhasini Subba Rao
Tom Boyles
Netanya S Utay
Robert J Wilkinson
Graeme Meintjes
Imperial College London · GBWellcome Centre for Infectious Diseases Research in Africa · ZAMadwaleni Hospital · ZANorth Manchester General Hospital · GBTexas A&M University · USThe University of Texas Medical Branch at Galveston · US

Funding

South Africa Tuberculosis AIDS Training (SATBAT)U2RTW007370 · FIC · WITS HEALTH CONSORTIUM (PTY), LTD · PI MARTINSON, NEIL A · 2007 to 2011
$1.9M
South Africa Tuberculosis/AIDS TrainingU2RTW007373 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI VAN DER HORST, CHARLES MICHAEL · 2007 to 2012
$1.4M
FIC NIH HHS U2R TW007370FIC NIH HHS U2R TW007373Medical Research Council U1175.02.002.0014PHS HHS 1U2RTW007373-01A1PHS HHS U2RTW007370Wellcome Trust 084323.088316Wellcome Trust 098316Wellcome Trust 104803
6 · The paper itself

Abstract

introductionCase fatality among in-patients with HIV-associated tuberculosis (HIV-TB) in Africa is high. We investigated the factors associated with mortality in a rural South African hospital.

methodsThis was a prospective observational study of HIV-TB in-patients, with death by 8 weeks the endpoint.

resultsOf 99 patients (median CD4 count 72 cells/mm³), 32 (32%) died after median 8-day TB treatment. TB was diagnosed microbiologically in 75/99 and clinico-radiologically in 24, with no mortality difference between these groups [31% versus 38% (P = 0.53)]. Median venous lactate was 5.5 mmol/L (interquartile range 3.9-6.2) in those who died and 3.1 mmol/L (interquartile range 2.2-4.1) in survivors (P < 0.001). In multivariable analysis, lactate ≥4 mmol/L [adjusted odds ratio (aOR) 9.8, 95% confidence interval (CI): 3.0 to 32.2], Glasgow Coma Score <15 (aOR 6.6, 95% CI: 1.5 to 29.6), CD4 count <50 cells per cubic millimeter (aOR 5.5, 95% CI: 1.6 to 18.5), and age ≥50 (aOR 7.7, 95% CI: 1.2 to 46.9) independently predicted death. In a nested case-control study, comparing those who died versus CD4-matched survivors, median plasma lipopolysaccharide concentrations were 93 and 57 pg/mL (P = 0.026) and intestinal fatty acid-binding protein, 132 and 0 pg/mL (P = 0.002).

conclusionsMortality was high and predicted by elevated lactate, likely reflecting a sepsis-syndrome secondary to TB or bacterial coinfection with intestinal barrier dysfunction appearing to contribute.

Indexed as

Bacterial TranslocationAdolescentAdultFemaleHIV InfectionsHumansLactic AcidMaleMiddle AgedMortalityProspective StudiesRural PopulationSouth AfricaSurvival AnalysisTuberculosisYoung AdultLactic Acid

Identifiers

PMID26186506
PMCPMC4625603
OpenAlexW2187573240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.